Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 176 (1), 117-23

Increased Expression of Urotensin II and Its Cognate Receptor GPR14 in Atherosclerotic Lesions of the Human Aorta

Affiliations

Increased Expression of Urotensin II and Its Cognate Receptor GPR14 in Atherosclerotic Lesions of the Human Aorta

Nicolas Bousette et al. Atherosclerosis.

Abstract

Urotensin II (U-II), a novel vasoactive peptide, possesses a wide range of cardiovascular effects. U-II binds a seven transmembrane spanning G-protein coupled receptor termed GPR14. In the present study, we have characterized U-II expression in both carotid and aortic atherosclerotic plaques. Using immunohistochemistry we demonstrated U-II immunoreactivity in endothelial, smooth muscle and inflammatory cells of both carotid and aortic plaques, with a clear propensity for intimal staining. Using quantitative real-time RT-PCR we observed both increased U-II and GPR14 mRNA expression in tissue extracts from abdominal aortic aneurysms. We also extended our PCR analysis to include leukocyte expression of U-II and GPR14. We found that lymphocytes were by far the largest producers of U-II mRNA. In contrast monocytes and macrophages were the largest producers of GPR14 mRNA, with relatively little expression in foam cells, lymphocytes, and platelets. Our findings qualitatively and quantitatively demonstrate increased expression of U-II in atherosclerosis with a large degree of inflammatory cell involvement. These findings suggest a possible role for U-II in the pathophysiology of atherosclerosis.

Similar articles

See all similar articles

Cited by 22 PubMed Central articles

See all "Cited by" articles

MeSH terms

LinkOut - more resources

Feedback